BioCentury | Oct 31, 2020
Product Development

U.K. BIA Antibody Taskforce picks COVID-19 mAb cocktail candidates

...and national registry to combat the pandemic. Sandi Wong Alchemab Therapeutics Ltd. Imperial...
BioCentury | May 16, 2020
Management Tracks

Bingham to lead U.K. push for a COVID-19 vaccine

...are re-tooling their drug discovery platforms to discover COVID-19 therapies: Bicycle Therapeutics plc (NASDAQ:BCYC) and Alchemab Therapeutics Ltd....
BioCentury | May 1, 2020
Product Development

How the U.K. healthcare sector is leveraging its strengths to beat COVID-19

...Therapeutics plc (NASDAQ:BCYC) is using its unique macrocycle platform to find new drugs for COVID-19. Alchemab Therapeutics Ltd....
Items per page:
1 - 3 of 3
BioCentury | Oct 31, 2020
Product Development

U.K. BIA Antibody Taskforce picks COVID-19 mAb cocktail candidates

...and national registry to combat the pandemic. Sandi Wong Alchemab Therapeutics Ltd. Imperial...
BioCentury | May 16, 2020
Management Tracks

Bingham to lead U.K. push for a COVID-19 vaccine

...are re-tooling their drug discovery platforms to discover COVID-19 therapies: Bicycle Therapeutics plc (NASDAQ:BCYC) and Alchemab Therapeutics Ltd....
BioCentury | May 1, 2020
Product Development

How the U.K. healthcare sector is leveraging its strengths to beat COVID-19

...Therapeutics plc (NASDAQ:BCYC) is using its unique macrocycle platform to find new drugs for COVID-19. Alchemab Therapeutics Ltd....
Items per page:
1 - 3 of 3